Archive for the ‘Pancreatic Cancer’ category

Cancer Fundraiser

June 29th, 2010

The Farber Center for Radiation Oncology

Presents

ROCKS AGAINST CANCER

A Fundraising Event for Entertainment Industry Foundation
benefiting EIF Cancer Programs.

Thursday, Sept 16th 7pm to 11pm

BLACK TIE ROCK & ROLL STYLE!

To purchase tickets or donate click here: Rocks Against Cancer Tickets

The event will take place at the Angel Orensanz Foundation for the Arts, situated on 172 Norfolk Street in the former Ansche Chesed Synagogue, the venue boasts superbly maintained mid-19th century architecture.

The lounge-style space will feature cocktails and food as well as performances by The Rotten Hill Gang, a six-piece band from London fronted by Mick Jones of The Clash. Eclectic Method featuring London natives Jonny Wilson, Ian Edgar and Geoff Gamlen – who helped pioneer the emerging art of audio-visual mixing since first cutting U2’s Mysterious Ways music video with the Beastie Boys’ Intergalactic as an experiment back in 2002 will close out the night.

The event also includes a silent auction of jewelry by Stephen Webster—three-time winner of the “British Luxury Jeweller of the Year” award and 2008 winner of “UK Jewellery Brand of the Year”—including specially designed bracelets supporting the fight against cancer with net proceeds benefiting EIF’s Cancer programs. Webster is widely known as the jeweler to the stars; his celebrity client list includes Madonna, Elizabeth Taylor, Jennifer Lopez, Kim Cattrall, and Christina Aguilera among others.

Some of EIF’s cancer programs include: Stand Up To Cancer (SU2C)Woman’s Cancer Research Fund, Brains on Bikes, Right Action for Woman, and the National Colorectal Research Alliance

If you are arriving from out of town please contact the Smyth – part of the Thompson Hotels at 85 West Broadway phone: 212.587.7000. We have reserved rooms at a special rate under the group name Rocks Against Cancer.

A special thanks to our current sponsors at the time this blog went out: Stephen Webster, Matthew Robbins Desings, Svendka, Warren Tricomi, and Elekta Inc.

  • Share/Bookmark

Pfizer’s Sutent Drug Slows Pancreatic Cancer

January 22nd, 2010

Pfizer Inc. announced final results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic neuroendocrine tumors, a type of cancer which originates in the hormone-producing area of the pancreas.

The drug more than doubled the time patients with pancreatic neuroendocrine tumors lived without disease progression compared with patients treated with placebo, according to study findings that will be presented Saturday at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium in Orlando, Fla.

“This trial advances our understanding of the use of novel targeted therapies in a patient population with limited treatment options,” said Mace Rothenberg, senior vice president of clinical development and medical affairs for Pfizer’s oncology business unit.

Pfizer is seeking regulatory approval for Sutent as a pancreatic cancer treatment in the U.S., Europe and Canada.

to read the full article and find out more go to businesswire.com

  • Share/Bookmark

Switch to our mobile site